搜索临床试验以:Urinary retention secondary to benign prostatic hyperplasia
总计476900个结果
-
Applied Biology, Inc.完全的
-
San Carlo di Nancy HospitalLampugnani Farmaceutici S.p.A. (Nerviano, Milan, Italy)完全的
-
Spectrum Pharmaceuticals, Inc终止
-
Spectrum Pharmaceuticals, Inc完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Peking University Third Hospital完全的良性前列腺增生症 | 前列腺癌
-
Boston Scientific Corporation完全的前列腺增生 | 良性前列腺增生症 | 前列腺增生,良性 | 前列腺肥大 | 前列腺肥大,良性 | 腺瘤,前列腺 | 前列腺腺瘤 | 雷祖姆多明尼加共和国, 捷克语, 瑞典
-
Boston Scientific Corporation完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
Pfizer's Upjohn has merged with Mylan to form Viatris...完全的
-
University of North Carolina, Chapel HillBTG International Inc.; Embolx, Inc.撤销
-
Robert W. Alexander, MD, FICSTerry, Glenn C., M.D.撤销
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do Sul完全的
-
Boryung Pharmaceutical Co., Ltd完全的
-
University Hospital Southampton NHS Foundation...BTG International Inc.未知
-
National Cheng-Kung University Hospital撤销
-
University of Kansas Medical Center未知
-
Boston Scientific Corporation完全的
-
St. Olavs HospitalNorwegian University of Science and Technology完全的
-
Astellas Pharma Global Development, Inc.完全的膀胱过度活动症 | 良性前列腺增生症美国, 加拿大, 捷克语, 法国, 德国, 意大利, 波兰, 西班牙, 英国